These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9538131)

  • 1. Loss of merlin-p85 protein complex in NF2-related tumors.
    Takeshima H; Nishi T; Yamamoto K; Kino T; Nakamura H; Saya H; Kochi M; Kuratsu JI; Ushio Y
    Int J Oncol; 1998 May; 12(5):1073-8. PubMed ID: 9538131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
    Kimura Y; Koga H; Araki N; Mugita N; Fujita N; Takeshima H; Nishi T; Yamashima T; Saido TC; Yamasaki T; Moritake K; Saya H; Nakao M
    Nat Med; 1998 Aug; 4(8):915-22. PubMed ID: 9701243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas.
    Gutmann DH; Giordano MJ; Fishback AS; Guha A
    Neurology; 1997 Jul; 49(1):267-70. PubMed ID: 9222206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
    Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
    Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
    Kimura Y; Saya H; Nakao M
    Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
    Stepanova DS; Semenova G; Kuo YM; Andrews AJ; Ammoun S; Hanemann CO; Chernoff J
    Cancer Res; 2017 Sep; 77(18):5026-5038. PubMed ID: 28729415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.
    Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA
    J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
    Mérel P; Hoang-Xuan K; Sanson M; Moreau-Aubry A; Bijlsma EK; Lazaro C; Moisan JP; Resche F; Nishisho I; Estivill X
    Genes Chromosomes Cancer; 1995 Jul; 13(3):211-6. PubMed ID: 7669741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.
    James MF; Lelke JM; Maccollin M; Plotkin SR; Stemmer-Rachamimov AO; Ramesh V; Gusella JF
    Neurobiol Dis; 2008 Feb; 29(2):278-92. PubMed ID: 17962031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study.
    Hitotsumatsu T; Iwaki T; Kitamoto T; Mizoguchi M; Suzuki SO; Hamada Y; Fukui M; Tateishi J
    Acta Neuropathol; 1997 Mar; 93(3):225-32. PubMed ID: 9083553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NF2 gene product merlin in arachnoid villi and meningiomas.
    Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J
    Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in neurofibromatosis 2 protein function can arise at multiple levels.
    Gutmann DH; Geist RT; Xu Hm; Kim JS; Saporito-Irwin S
    Hum Mol Genet; 1998 Mar; 7(3):335-45. PubMed ID: 9466988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
    Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
    J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
    Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
    Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.
    James MF; Stivison E; Beauchamp R; Han S; Li H; Wallace MR; Gusella JF; Stemmer-Rachamimov AO; Ramesh V
    Mol Cancer Res; 2012 May; 10(5):649-59. PubMed ID: 22426462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
    Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.